TIME and Statista have named 500 top performing U.S. companies In the U.S., large companies dominate headlines and industry discussions, but mid-sized companies, which have revenues between $100 ...

Reports say Novo Nordisk may have inadvertently let generics of its GLP-1 drug semaglutide for diabetes and obesity launch in Canada early next year.